跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Optamol - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Optamol
Approved
STANDARD
Optamol
Amanta Healthcare Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ca5f85b0be25cb03
Company
Amanta Healthcare Ltd.
Type
Standard
Approval Details
Approval Id
ca5f85b0be25cb03
Drug Approval Philippines Name
Optamol
Product Name
Optamol
Registration Number
DR-XY36653
Brand Name
Optamol
Generic Name
Timolol (As Maleate)
Dosage Form
Ophthalmic Solution (Eye Drops)
Dosage Strength
2.5 mg/Ml (0.25%w/v)
Manufacturer
Amanta Healthcare Ltd.
Importer
Endure Medical, Inc.
Distributor
Endure Medical, Inc.
Issuance Date
28 September 2024
Expiry Date
16 September 2029
Pharmacologic Category
Antiglaucoma / Beta-Adrenergic Blocking Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ca5f85b0be25cb03
Type
Standard
Back to Philippines FDA Approvals